DeepGene-BC: Deep Learning-Based Breast Cancer Subtype Prediction via Somatic Point Mutation Profiles.

: Molecular subtyping of breast cancer usually relies on transcriptomic profiles, a method constrained by limitations in robustness and clinical applicability. While somatic point mutations represent a stable genomic alternative, their predictive utility is hindered by high dimensionality, extreme sparsity, and weak single-gene associations. : Here, we present deepGene-BC, a deep learning framework that synergizes a pathway-informed feature selection strategy with a hybrid neural network tailored for sparse binary data. To distill sparse genome-wide mutations into a compact and interpretable feature set, deepGene-BC integrates mutation recurrence filtering, curated pathway priors, and mutual information-based gene prioritization. These refined features are subsequently modeled using a specialized hybrid architecture designed to capture complex linear effects, feature interactions, and higher-order nonlinear patterns. : When benchmarked against an independent test set ( = 273) from the TCGA breast cancer cohort, deepGene-BC achieved an overall accuracy of 77.3% and an average sensitivity of 75.2%, accompanied by a strong overall discriminative performance (macro-averaged AU-ROC = 0.94, 95% CI: 0.92-0.96). : By effectively combining biologically informed feature engineering with deep learning, deepGene-BC holds significant promise for non-invasive molecular stratification and precision oncology.